Search research articles
Contact Us
Filters
Showing results (111-120 of 182) with videos related to
Page
of 19
Sort By:
Blood Cancer Journal
|
May 11, 2021
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome
Yucai Wang, Sutapa Sinha, Linda E Wellik, et al.
Blood
|
April 20, 2021
The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL
Sameer A Parikh, Kari G Rabe, Neil E Kay, et al.
The Oncologist
|
September 5, 2020
Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia
Paul J Hampel, Timothy G Call, Kari G Rabe, et al.
Blood
|
January 9, 2024
Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature
Salma B Abdelbaky, Brian Giacopelli, Kari G Rabe, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 4, 2026
Genetic risk and immune dysregulation of classic Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma: a multicentric study
Mingfei Yan, Sameer A Parikh, Michelly K Sampaio De Melo, et al.
Hematological Oncology
|
November 22, 2021
Differential transcriptomic profiling in ibrutinib-naïve versus ibrutinib-resistant Richter syndrome
Hanyin Wang, Shulan Tian, Qing Zhao, et al.
Haematologica
|
October 15, 2020
Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration
Deborah M Stephens, Ken Boucher, Elizabeth Kander, et al.
American Journal of Hematology
|
November 4, 2017
Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases
Massimo Gentile, Tait D Shanafelt, Francesca R Mauro, et al.
Annals of Hematology
|
June 4, 2020
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes
William J Archibald, Kari G Rabe, Brian F Kabat, et al.
Leukemia
|
May 5, 2023
Relationship among three common hematological premalignant conditions
Nicholas J Boddicker, Sameer A Parikh, Aaron D Norman, et al.
Page
of 19
Search research articles
Search
Showing results (111-120 of 182) with videos related to
Sort By:
Page
of 19
Blood Cancer Journal
|
May 11, 2021
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome
Yucai Wang, Sutapa Sinha, Linda E Wellik, et al.
Blood
|
April 20, 2021
The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL
Sameer A Parikh, Kari G Rabe, Neil E Kay, et al.
The Oncologist
|
September 5, 2020
Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia
Paul J Hampel, Timothy G Call, Kari G Rabe, et al.
Blood
|
January 9, 2024
Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature
Salma B Abdelbaky, Brian Giacopelli, Kari G Rabe, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 4, 2026
Genetic risk and immune dysregulation of classic Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma: a multicentric study
Mingfei Yan, Sameer A Parikh, Michelly K Sampaio De Melo, et al.
Hematological Oncology
|
November 22, 2021
Differential transcriptomic profiling in ibrutinib-naïve versus ibrutinib-resistant Richter syndrome
Hanyin Wang, Shulan Tian, Qing Zhao, et al.
Haematologica
|
October 15, 2020
Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration
Deborah M Stephens, Ken Boucher, Elizabeth Kander, et al.
American Journal of Hematology
|
November 4, 2017
Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases
Massimo Gentile, Tait D Shanafelt, Francesca R Mauro, et al.
Annals of Hematology
|
June 4, 2020
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes
William J Archibald, Kari G Rabe, Brian F Kabat, et al.
Leukemia
|
May 5, 2023
Relationship among three common hematological premalignant conditions
Nicholas J Boddicker, Sameer A Parikh, Aaron D Norman, et al.
Page
of 19